Kallioniemi O P, Hietanen T, Mattila J, Lehtinen M, Lauslahti K, Koivula T
Eur J Cancer Clin Oncol. 1987 Mar;23(3):277-82. doi: 10.1016/0277-5379(87)90071-x.
The prognostic impact of DNA content and S-phase fraction (SPF) of tumour cells was studied in 93 patients with primary breast cancer. Aneuploid DNA content and high SPF were clearly associated with poor differentiation state of tumours and absence of steroid, especially progesterone receptors. Aneuploidy and high SPF tended to become more common with increasing primary tumour size, with more extensive nodal involvement and with more advanced stage of the cancer. Patients with diploid tumours had a slightly longer disease-free interval and survival than those with aneuploid tumours, whereas below median SPF as compared to above median SPF was associated with significantly longer (P less than 0.01) relapse-free interval and survival in patients with stage II-III cancer. We conclude that the DNA analysis of tumour cells is a promising method for the estimation of prognosis in breast cancer patients.
对93例原发性乳腺癌患者的肿瘤细胞DNA含量和S期分数(SPF)的预后影响进行了研究。非整倍体DNA含量和高SPF与肿瘤的低分化状态以及类固醇尤其是孕激素受体的缺乏明显相关。随着原发性肿瘤大小的增加、淋巴结受累范围的扩大以及癌症分期的进展,非整倍体和高SPF往往变得更为常见。二倍体肿瘤患者的无病间期和生存期比非整倍体肿瘤患者略长,而在II - III期癌症患者中,与高于中位数的SPF相比,低于中位数的SPF与显著更长(P小于0.01)的无复发生存期和生存期相关。我们得出结论,肿瘤细胞的DNA分析是评估乳腺癌患者预后的一种有前景的方法。